Southern Korea authorises AstraZeneca COVID-19 therapy Evusheld for vulnerable individuals
SEOUL: South Korea on Thursday (Jun 30) authorised AstraZeneca PLC’s antibody-based therapy for preventing COVID-19 infection in people with a poor immune reaction, increasing its choices as it works to relieve the pandemic problem on the healthcare system. The Ministry of Food and Drug Safety given emergency use authorisation forContinue Reading